PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers

Rhea-AI Summary

On December 14, 2021, Veeva Systems (NYSE: VEEV) announced PharmaEssentia's adoption of Veeva Data Cloud to aid in the launch of BESREMi, a novel therapy for polycythemia vera (PV). The platform will provide critical patient insights for targeting healthcare providers and analyzing patient journeys. PharmaEssentia's U.S. General Manager highlighted the platform's role in enhancing visibility of patient data, while Veeva's CEO emphasized its support for various analytics and workflow operations. The collaboration aims to improve HCP education about the new treatment.

Positive

• PharmaEssentia's adoption of Veeva Data Cloud enhances their launch strategy for BESREMi.
• Access to anonymized patient-level data allows for better targeting of healthcare providers.
• Veeva Data Cloud supports multiple analytics and operations workflows for improved HCP education.

Negative

• None.

PLEASANTON, Calif., Dec. 14, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that PharmaEssentia has adopted Veeva Data Cloud to support the launch of BESREMi, a new therapy for polycythemia vera (PV), a rare blood cancer. Veeva Longitudinal Patient Data will provide essential insights to help the company reach hard-to-find patient populations through healthcare provider (HCP) targeting and patient journey analytics.

"Veeva Data Cloud has been a great asset for our commercial go-to-market operations and launch strategy," said Meredith Manning, U.S. general manager at PharmaEssentia U.S.A Corporation. "In our specialized market, the dynamics are complex. With Veeva Data Cloud, we have access to anonymized patient-level historical diagnoses, concomitant treatments, and medical procedures, across all therapeutic areas. This enhanced visibility gives us a deeper understanding of the full patient experience and helps us find and engage the right prescribing HCPs."

"PharmaEssentia is an innovative biotechnology company taking a data-driven approach to its product launch," said Asaf Evenhaim, CEO, Veeva Crossix. "With Veeva Data Cloud, PharmaEssentia gains a single data source to support multiple commercial analytics and operations workflows so the company can better educate key HCPs on its important new treatment option."

The company's adoption of Veeva Data Cloud builds on its long-term success with other applications from the Veeva Commercial Cloud, including solutions for multichannel engagementand commercial content. These capabilities facilitate smarter, compliant HCP interactions across all channels.

Veeva Data Cloud brings together diverse data assets, including retail and specialty pharmacy distribution channels, as well as insurers and pharmacy benefit managers (PBMs) in the U.S. market. Veeva Data Cloud is powered by the Veeva Crossix Data Platform, a world-class technology platform built for the development and delivery of large-scale patient data and analytics.

Additional Information
For more on Veeva Data Cloud, visit: veeva.com/DataCloud 
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems 
Follow @veevasystems on Twitter: twitter.com/veevasystems 

About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Contact:

Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pharmaessentia-selects-veeva-data-cloud-to-support-launch-of-novel-therapy-for-rare-chronic-blood-cancers-301443938.html

SOURCE Veeva Systems

FAQ

What is Veeva Data Cloud and how is it being used by PharmaEssentia?

Veeva Data Cloud is a platform adopted by PharmaEssentia to support the launch of BESREMi, providing critical insights for targeting healthcare providers and analyzing patient journeys.

What therapy is PharmaEssentia launching with the help of Veeva Systems?

PharmaEssentia is launching BESREMi, a new therapy for polycythemia vera (PV), with the assistance of Veeva Data Cloud.

When did PharmaEssentia announce the adoption of Veeva Data Cloud?

PharmaEssentia announced the adoption of Veeva Data Cloud on December 14, 2021.

How does Veeva Data Cloud benefit PharmaEssentia in its market operations?

Veeva Data Cloud provides PharmaEssentia with anonymized patient-level data that enhances visibility and understanding of patient experiences, aiding in the targeting of healthcare providers.